NewAmsterdam Pharma Company N.V. (NAMS) vs Recursion Pharmaceuticals, Inc. (RXRX)

• NewAmsterdam Pharma Company N.V. NAMS 19.29 ▲ +2.12%
• Recursion Pharmaceuticals, Inc. RXRX 3.59 ▲ +2.57%

NewAmsterdam Pharma Company N.V. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. NewAmsterdam Pharma Company N.V. and Recursion Pharmaceuticals, Inc. are of similar size ($2.3B and $2.2B). Recursion Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 56.2% against −26.4%. Recursion Pharmaceuticals, Inc. has the higher net margin (−697.1% vs −789.9%) and the lower return on invested capital (−88.5% vs −23.1%). Across the 17 metrics below, NewAmsterdam Pharma Company N.V. leads on 9 and Recursion Pharmaceuticals, Inc. on 8.